Manhattan Scientifics, Inc. (MHTX)
USD 0.0
(16.67%)
USD 0.0
(16.67%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 60 Thousand USD | -45.45% |
| 2022 | 110 Thousand USD | -15.38% |
| 2021 | 130 Thousand USD | 25.0% |
| 2020 | 104 Thousand USD | 33.33% |
| 2019 | 78 Thousand USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | -100.0% |
| 2016 | 2.41 Million USD | 1.51% |
| 2015 | 2.37 Million USD | -19.72% |
| 2014 | 2.96 Million USD | 12.5% |
| 2013 | 2.63 Million USD | 96.05% |
| 2012 | 1.34 Million USD | 496.89% |
| 2011 | 225 Thousand USD | 581.82% |
| 2010 | 33 Thousand USD | -96.79% |
| 2009 | 1.02 Million USD | 0.0% |
| 2008 | 1.02 Million USD | 3015.15% |
| 2007 | 33 Thousand USD | -97.08% |
| 2006 | 1.13 Million USD | -16.89% |
| 2005 | 1.36 Million USD | -27.09% |
| 2004 | 1.86 Million USD | -4.21% |
| 2003 | 1.95 Million USD | 107.01% |
| 2002 | 942 Thousand USD | 16.01% |
| 2001 | 812 Thousand USD | 41.22% |
| 2000 | 575 Thousand USD | 109.09% |
| 1999 | 275 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 60 Thousand USD | 0.0% |
| 2024 Q2 | 60 Thousand USD | 0.0% |
| 2023 Q3 | 60 Thousand USD | -14.29% |
| 2023 Q1 | 70 Thousand USD | -36.36% |
| 2023 Q2 | 70 Thousand USD | 0.0% |
| 2023 Q4 | 60 Thousand USD | 0.0% |
| 2023 FY | 60 Thousand USD | -45.45% |
| 2022 Q1 | 135 Thousand USD | 3.85% |
| 2022 FY | 110 Thousand USD | -15.38% |
| 2022 Q3 | 139 Thousand USD | -2.8% |
| 2022 Q4 | 110 Thousand USD | -20.86% |
| 2022 Q2 | 143 Thousand USD | 5.93% |
| 2021 Q4 | 130 Thousand USD | 4.84% |
| 2021 Q1 | 110 Thousand USD | 5.77% |
| 2021 Q2 | 117 Thousand USD | 6.36% |
| 2021 Q3 | 124 Thousand USD | 5.98% |
| 2021 FY | 130 Thousand USD | 25.0% |
| 2020 Q2 | 91 Thousand USD | 7.06% |
| 2020 FY | 104 Thousand USD | 33.33% |
| 2020 Q1 | 85 Thousand USD | 8.97% |
| 2020 Q4 | 104 Thousand USD | 7.22% |
| 2020 Q3 | 97 Thousand USD | 6.59% |
| 2019 Q3 | - USD | 0.0% |
| 2019 Q2 | - USD | -100.0% |
| 2019 Q1 | 50 Thousand USD | 0.0% |
| 2019 FY | 78 Thousand USD | 0.0% |
| 2019 Q4 | 78 Thousand USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2017 FY | - USD | -100.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q2 | - USD | -100.0% |
| 2017 Q1 | 544 Thousand USD | -77.46% |
| 2017 Q3 | - USD | 0.0% |
| 2016 Q1 | 2.39 Million USD | 0.63% |
| 2016 Q3 | 2.52 Million USD | 2.64% |
| 2016 Q4 | 2.41 Million USD | -4.32% |
| 2016 FY | 2.41 Million USD | 1.51% |
| 2016 Q2 | 2.45 Million USD | 2.72% |
| 2015 Q3 | 2.26 Million USD | -14.38% |
| 2015 Q2 | 2.64 Million USD | -12.72% |
| 2015 Q1 | 3.02 Million USD | 2.19% |
| 2015 Q4 | 2.37 Million USD | 5.13% |
| 2015 FY | 2.37 Million USD | -19.72% |
| 2014 FY | 2.96 Million USD | 12.5% |
| 2014 Q1 | 2.76 Million USD | 5.13% |
| 2014 Q2 | 2.86 Million USD | 3.4% |
| 2014 Q3 | 2.89 Million USD | 1.22% |
| 2014 Q4 | 2.96 Million USD | 2.24% |
| 2013 FY | 2.63 Million USD | 96.05% |
| 2013 Q3 | 2.51 Million USD | 32.54% |
| 2013 Q4 | 2.63 Million USD | 4.78% |
| 2013 Q2 | 1.89 Million USD | 111.61% |
| 2013 Q1 | 896 Thousand USD | -33.28% |
| 2012 Q4 | 1.34 Million USD | -0.22% |
| 2012 Q3 | 1.34 Million USD | 45.04% |
| 2012 Q2 | 928 Thousand USD | 4.5% |
| 2012 Q1 | 888 Thousand USD | 294.67% |
| 2012 FY | 1.34 Million USD | 496.89% |
| 2011 Q4 | 225 Thousand USD | -53.42% |
| 2011 Q2 | 483 Thousand USD | 0.0% |
| 2011 Q1 | 483 Thousand USD | 1363.64% |
| 2011 FY | 225 Thousand USD | 581.82% |
| 2011 Q3 | 483 Thousand USD | 0.0% |
| 2010 Q2 | 1.02 Million USD | 0.0% |
| 2010 Q4 | 33 Thousand USD | -96.79% |
| 2010 Q3 | 1.02 Million USD | 0.0% |
| 2010 FY | 33 Thousand USD | -96.79% |
| 2010 Q1 | 1.02 Million USD | 0.0% |
| 2009 Q4 | 1.02 Million USD | 0.0% |
| 2009 FY | 1.02 Million USD | 0.0% |
| 2009 Q1 | 1.02 Million USD | 0.0% |
| 2009 Q2 | 1.02 Million USD | 0.0% |
| 2009 Q3 | 1.02 Million USD | 0.0% |
| 2008 Q3 | 1.02 Million USD | 0.0% |
| 2008 Q2 | 1.02 Million USD | 0.1% |
| 2008 FY | 1.02 Million USD | 3015.15% |
| 2008 Q1 | 1.02 Million USD | 3015.15% |
| 2008 Q4 | 1.02 Million USD | -0.1% |
| 2007 Q1 | 1.13 Million USD | 0.0% |
| 2007 FY | 33 Thousand USD | -97.08% |
| 2007 Q4 | 33 Thousand USD | -96.9% |
| 2007 Q3 | 1.06 Million USD | 0.09% |
| 2007 Q2 | 1.06 Million USD | -6.18% |
| 2006 Q3 | 1.1 Million USD | -16.79% |
| 2006 Q4 | 1.13 Million USD | 2.91% |
| 2006 Q1 | 1.32 Million USD | -2.94% |
| 2006 Q2 | 1.32 Million USD | 0.0% |
| 2006 FY | 1.13 Million USD | -16.89% |
| 2005 Q1 | 1.87 Million USD | 0.11% |
| 2005 Q2 | 1.87 Million USD | 0.16% |
| 2005 FY | 1.36 Million USD | -27.09% |
| 2005 Q3 | 1.88 Million USD | 0.53% |
| 2005 Q4 | 1.36 Million USD | -27.67% |
| 2004 FY | 1.86 Million USD | -4.21% |
| 2004 Q3 | 1.7 Million USD | 0.59% |
| 2004 Q2 | 1.69 Million USD | 4.49% |
| 2004 Q1 | 1.62 Million USD | -16.67% |
| 2004 Q4 | 1.86 Million USD | 9.37% |
| 2003 Q1 | 845 Thousand USD | -10.3% |
| 2003 Q2 | 823 Thousand USD | -2.6% |
| 2003 FY | 1.95 Million USD | 107.01% |
| 2003 Q4 | 1.95 Million USD | 136.36% |
| 2003 Q3 | 825 Thousand USD | 0.24% |
| 2002 FY | 942 Thousand USD | 16.01% |
| 2002 Q1 | 815 Thousand USD | 0.37% |
| 2002 Q2 | 814 Thousand USD | -0.12% |
| 2002 Q3 | 918 Thousand USD | 12.78% |
| 2002 Q4 | 942 Thousand USD | 2.61% |
| 2001 Q4 | 812 Thousand USD | -0.37% |
| 2001 Q3 | 815 Thousand USD | 43.49% |
| 2001 Q1 | 571 Thousand USD | -0.7% |
| 2001 FY | 812 Thousand USD | 41.22% |
| 2001 Q2 | 568 Thousand USD | -0.53% |
| 2000 Q2 | 275 Thousand USD | 0.0% |
| 2000 Q4 | 575 Thousand USD | -0.35% |
| 2000 Q3 | 577 Thousand USD | 109.82% |
| 2000 Q1 | 275 Thousand USD | 0.0% |
| 2000 FY | 575 Thousand USD | 109.09% |
| 1999 FY | 275 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| AVITA Medical, Inc. | 449.48 Thousand USD | 86.651% |
| Össur hf. | 467.73 Million USD | 99.987% |
| QHSLab, Inc. | 1.78 Million USD | 96.632% |
| Wellstar International, Inc. | 51.36 Million USD | 99.883% |
| Össur hf. | 467.73 Million USD | 99.987% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 524.71 Thousand USD | 88.565% |
| Aurora Spine Corporation | 2.67 Million USD | 97.753% |
| BrainsWay Ltd. | 471 Thousand USD | 87.261% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 14.83 Million USD | 99.595% |
| Hamilton Thorne Ltd. | 27.81 Million USD | 99.784% |
| Vivos Inc. | - USD | -Infinity% |
| Kelyniam Global, Inc. | 496.39 Thousand USD | 87.913% |
| REMSleep Holdings, Inc. | 178.11 Thousand USD | 66.314% |
| Zecotek Photonics Inc. | 3.22 Million USD | 98.138% |
| Avitar, Inc. | 5.26 Million USD | 98.86% |
| Nanomix Corporation | 11.4 Million USD | 99.474% |
| EKF Diagnostics Holdings plc | 5.21 Million USD | 98.85% |
| Theraclion SA | 1.95 Million EUR | 96.924% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 1.78 Million USD | 96.643% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.69 Million USD | 96.468% |
| Lombard Medical, Inc. | 32.29 Million USD | 99.814% |
| ALR Technologies Inc. | 19.26 Million USD | 99.689% |
| Stratec SE | 156.16 Million USD | 99.962% |
| Vycor Medical, Inc. | 1.11 Million USD | 94.596% |
| Heart Tronics, Inc. | 209.28 Thousand USD | 71.331% |
| MicroPort Scientific Corporation | 1.69 Billion USD | 99.996% |
| VMS Rehab Systems, Inc. | 133.52 USD | -44837.088% |
| NewCardio, Inc. | 3 Million USD | 98.0% |
| Guided Therapeutics, Inc. | 2.05 Million USD | 97.085% |
| Ingen Technologies, Inc. | 631.15 Thousand USD | 90.494% |
| Odyssey Group International, Inc. | 2.14 Million USD | 97.202% |
| CYduct Diagnostics, Inc. | 670 Thousand USD | 91.045% |
| Wellness Center USA, Inc. | 4.04 Million USD | 98.516% |
| SANUWAVE Health, Inc. | 31.94 Million USD | 99.812% |
| IR-Med Inc. | 161 Thousand USD | 62.733% |
| Perimeter Medical Imaging AI, Inc. | 192.89 Thousand USD | 68.895% |
| Polarean Imaging plc | 216.38 Thousand USD | 72.272% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | 3.17 Million USD | 98.108% |
| Nu-Med Plus, Inc. | 100 Thousand USD | 40.0% |
| Capital Group Holdings, Inc. | 4944.00 USD | -1113.592% |
| ADM Tronics Unlimited, Inc. | 799.65 Thousand USD | 92.497% |
| Medical Supply International USA, Inc. | 227 Thousand USD | 73.569% |
| Urologix, Inc. | 5.33 Million USD | 98.875% |
| Rapid Therapeutic Science Laboratories, Inc. | 3.83 Million USD | 98.434% |
| Nexeon MedSystems Inc. | 4.21 Million USD | 98.577% |
| SS Innovations International, Inc. | 8.21 Million USD | 99.27% |
| Qualis Innovations, Inc. | 9102.00 USD | -559.196% |
| Smith & Nephew plc | 3.07 Billion USD | 99.998% |
| NIOX Group Plc | 1.4 Million USD | 95.715% |
| Fuse Medical, Inc. | 1.99 Million USD | 96.99% |
| Broncus Holding Corporation | 2.35 Million USD | 97.452% |
| Brain Scientific Inc. | 2.86 Million USD | 97.905% |
| Pressure BioSciences, Inc. | 22.75 Million USD | 99.736% |
| Health Logic Interactive Inc. | 40.44 Thousand USD | -48.361% |